Company: INMB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001213900-25-041072
Chunk: 72

Company: Inmune Bio, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 3
Chunk 72
---
 applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the fiscal quarter
ended March 31, 2025, none of the Company’s directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement,
or a non-Rule 10b5-1 trading arrangement, in each case as defined in Item 408 of Regulation S-K.

Item 6. Exhibits 

    No.
     
    Description 

    10.2
     
    License Agreement, dated February 6, 2025, between INmune Bio Inc. and Great Ormond Street Hospital for Children NHS Foundation Trust (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on February 10, 2025)

    10.2
     
    Termination Letter, dated February 6, 2025, between INmune Bio Inc. and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on February 10, 2025)

    31.1
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer*

    31.2
     
    Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer*

    32.1
     
    Section 1350 Certification of Chief Executive Officer**

    32.2
     
    Section 1350 Certification of Chief Financial Officer**

    101.INS
     
    Inline XBRL Instance Document.

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document.

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    101.PRE
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

28

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934,